Literature DB >> 12475783

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.

Marc Prentki1, Erik Joly, Wissal El-Assaad, Raphaël Roduit.   

Abstract

Beta-cells possess inherent mechanisms to adapt to overnutrition and the prevailing concentrations of glucose, fatty acids, and other fuels to maintain glucose homeostasis. However, this is balanced by potentially harmful actions of the same nutrients. Both glucose and fatty acids may cause good/adaptive or evil/toxic actions on the beta-cell, depending on their concentrations and the time during which they are elevated. Chronic high glucose dramatically influences beta-cell lipid metabolism via substrate availability, changes in the activity and expression of enzymes of glucose and lipid metabolism, and modifications in the expression level of key transcription factors. We discuss here the emerging view that beta-cell "glucotoxicity" is in part indirectly caused by "lipotoxicity," and that beta-cell abnormalities will become particularly apparent when both glucose and circulating fatty acids are high. We support the concept that elevated glucose and fatty acids synergize in causing toxicity in islets and other organs, a process that may be instrumental in the pleiotropic defects associated with the metabolic syndrome and type 1 and type 2 diabetes. The mechanisms by which hyperglycemia and hyperlipidemia alter insulin secretion are discussed and a model of beta-cell "glucolipotoxicity" that implicates alterations in beta-cell malonyl-CoA concentrations; peroxisome proliferator-activated receptor-alpha and -gamma and sterol regulatory element binding protein-1c expression; and lipid partitioning is proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475783     DOI: 10.2337/diabetes.51.2007.s405

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  118 in total

Review 1.  [Obesity: ectopic fat distribution and the heart].

Authors:  Dirk Müller-Wieland; Birgit Knebel; Jutta Haas; Martin Merkel; Jörg Kotzka
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

2.  The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats.

Authors:  Ping-Ping Li; Song Shan; Yue-Teng Chen; Zhi-Qiang Ning; Su-Juan Sun; Quan Liu; Xian-Ping Lu; Ming-Zhi Xie; Zhu-Fang Shen
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 3.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

Authors:  C Xiao; A Giacca; A Carpentier; G F Lewis
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

Review 5.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

6.  Obesity and the beta cell: lessons from leptin.

Authors:  Kevin D Niswender; Mark A Magnuson
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

8.  Dual role of proapoptotic BAD in insulin secretion and beta cell survival.

Authors:  Nika N Danial; Loren D Walensky; Chen-Yu Zhang; Cheol Soo Choi; Jill K Fisher; Anthony J A Molina; Sandeep Robert Datta; Kenneth L Pitter; Gregory H Bird; Jakob D Wikstrom; Jude T Deeney; Kirsten Robertson; Joel Morash; Ameya Kulkarni; Susanne Neschen; Sheene Kim; Michael E Greenberg; Barbara E Corkey; Orian S Shirihai; Gerald I Shulman; Bradford B Lowell; Stanley J Korsmeyer
Journal:  Nat Med       Date:  2008-01-27       Impact factor: 53.440

9.  Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets.

Authors:  Lara Bellini; Mélanie Campana; Claude Rouch; Marta Chacinska; Marco Bugliani; Kelly Meneyrol; Isabelle Hainault; Véronique Lenoir; Jessica Denom; Julien Véret; Nadim Kassis; Bernard Thorens; Mark Ibberson; Piero Marchetti; Agnieszka Blachnio-Zabielska; Céline Cruciani-Guglielmacci; Carina Prip-Buus; Christophe Magnan; Hervé Le Stunff
Journal:  Diabetologia       Date:  2018-05-12       Impact factor: 10.122

10.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.

Authors:  Lutfi Abu-Elheiga; Martin M Matzuk; Parichher Kordari; WonKeun Oh; Tattym Shaikenov; Ziwei Gu; Salih J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.